Advanced search
Publication Cover
Acta Cardiologica Volume 79, 2024 - Issue 2
Submit an article Journal homepage
39
Views
1
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Predictors of MACE following PPCI in patients with a prior history of CABG

Hamed Talakooba Cardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran
,
Roya Hamrahib Rajaie Cardiovascular Medical and Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
,
MohammadHossein MozafaryBazarganyb Rajaie Cardiovascular Medical and Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
,
Ehsan Khalilipurc Cardiovascular Intervention Research Center, Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
,
Hooman Bakhshandehd Department of Epidemiology, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
,
Mohammad Mahdi Kazemie Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
&
Mohsen Maadanic Cardiovascular Intervention Research Center, Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, IranCorrespondence[email protected]
 show all
Pages 123-126 | Received 30 Aug 2023, Accepted 01 Sep 2023, Published online: 28 Sep 2023

References

  • Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the coronary artery bypass graft surgery trialists collaboration. Lancet. 1994;344(8922):563–570. doi: 10.1016/s0140-6736(94)91963-1.
  • Ferrari G, Karlsson J, Cao Y, et al. Quality of life after percutaneous coronary intervention in No-Touch saphenous vein grafts is significantly better than in conventional vein grafts. Braz J Cardiovasc Surg. 2022;37(4):430–438. doi: 10.21470/1678-9741-2021-0576.
  • Beerkens FJ, Claessen BE, Mahan M, et al. Contemporary coronary artery bypass graft surgery and subsequent percutaneous revascularization. Nat Rev Cardiol. 2022;19(3):195–208. doi: 10.1038/s41569-021-00612-6.
  • Gaglia MA, Jr., Torguson R, Xue Z, et al. Outcomes of patients with acute myocardial infarction from a saphenous vein graft culprit undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2011;78(1):23–29. doi: 10.1002/ccd.22873.
  • Dimagli A, Cancelli G, Soletti GJ, et al. Percutaneous coronary intervention versus repeat surgical revascularization in patients with prior coronary artery bypass grafting: a systematic review and meta-analysis. JTCVS Open. 2022;12:177–191. doi: 10.1016/j.xjon.2022.10.006.
  • Chen J-L, Gao R-L, Yang Y-J Clinical results of percutaneous intervention in saphenous venous graft and arterial graft lesions in patients with restenosis of previous coronary artery bypass surgery. Chinese J Cardiol. 2004;32(1):17–19.
  • Brilakis ES, Rao SV, Banerjee S, et al. Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the national cardiovascular data registry. JACC Cardiovasc Interv. 2011;4(8):844–850. doi: 10.1016/j.jcin.2011.03.018.
  • Brilakis ES, O'Donnell CI, Penny W, et al. Percutaneous coronary intervention in native coronary arteries versus bypass grafts in patients with prior coronary artery bypass graft surgery: insights from the veterans affairs clinical assessment, reporting, and tracking program. JACC Cardiovasc Interv. 2016;9(9):884–893. doi: 10.1016/j.jcin.2016.01.034.
  • Brilakis ES, Lee M, Mehilli J, et al. Saphenous vein graft interventions. Curr Treat Options Cardiovasc Med. 2014;16(5):301.
  • Al Suwaidi J, Velianou JL, Berger PB, et al. Primary percutaneous coronary interventions in patients with acute myocardial infarction and prior coronary artery bypass grafting. Am Heart J. 2001;142(3):452–459. doi: 10.1067/mhj.2001.117319.
  • Yang M, Guo F, Yang Y-J, et al. Prognostic value of preoperative assessment of left ventricular function in patients undergoing percutaneous coronary intervention. RCM. 2023;24(3):80.
  • Azzalini L, Millán X, Ly HQ, et al. Direct stenting versus pre-dilation in ST-elevation myocardial infarction: a systematic review and meta-analysis. J Interv Cardiol. 2015;28(2):119–131. doi: 10.1111/joic.12190.
  • Bessonov I, Zyrianov I, Kuznetsov V, et al. TCTAP A-024 comparison of direct stenting versus pre-dilation in ST-Elevation myocardial infarction. J Am Coll Cardiol. 2016;67(16): s10–S. doi: 10.1016/j.jacc.2016.03.035.
  • Vijayarajan V, Ekmejian A, Cohen R, et al. Direct stenting versus stenting after pre-dilation in primary PCI for ST-elevation myocardial infarction. Heart Lung Circul. 2019;28:S394. doi: 10.1016/j.hlc.2019.06.608.
  • Xu MC, Zeng HS, Fan L, et al. Effects of post-dilation on coronary blood flow and MACE events following primary percutaneous coronary intervention in patients with STEMI. J Hainan Med Coll. 2022;28(11).
  • Kammler J, Kypta A, Hofmann R, et al. TIMI 3 flow after primary angioplasty is an important predictor for outcome in patients with acute myocardial infarction. Clin Res Cardiol. 2009;98(3):165–170. doi: 10.1007/s00392-008-0735-9.
  • Garcia-Alvarez A, Arzamendi D, Loma-Osorio P, et al. 272 Left main disease and postprocedural TIMI 3, but not TIMI 2, coronary blood flow predict survival in patients with cardiogenic shock complicating acute myocardial infarction. Eur J Heart Fail Suppl. 2008;7(S1):67–68. doi: 10.1016/S1567-4215(08)60184-8.
  • Gharacholou SM, Del-Carpio Munoz F, Motiei A, et al. Characteristics and Long-Term outcomes of patients with prior coronary artery bypass grafting undergoing primary percutaneous coronary intervention for ST-Segment elevation myocardial infarction. Am J Cardiol. 2020;135:1–8. doi: 10.1016/j.amjcard.2020.08.039.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.